In the last trading session, 1.22 million shares of the 908 Devices Inc (NASDAQ:MASS) were traded, and its beta was 0.46. Most recently the company’s share price was $4.53, and it changed around $0.37 or 8.89% from the last close, which brings the market valuation of the company to $160.04M. MASS currently trades at a discount to its 52-week high of $7.56, offering almost -66.89% off that amount. The share price’s 52-week low was $1.81, which indicates that the current value has risen by an impressive 60.04% since then. We note from 908 Devices Inc’s average daily trading volume that its 10-day average is 1.47 million shares, with the 3-month average coming to 3.22 million.
908 Devices Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended MASS as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. 908 Devices Inc is expected to report earnings per share of -0.25 for the current quarter.
908 Devices Inc (NASDAQ:MASS) trade information
Instantly MASS has showed a green trend with a performance of 8.89% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 4.75 on recent trading dayincreased the stock’s daily price by 4.63%. The company’s shares are currently up 105.91% year-to-date, but still up 10.22% over the last five days. On the other hand, 908 Devices Inc (NASDAQ:MASS) is 66.54% up in the 30-day period. We can see from the shorts that 2.25 million shares have been sold at a short interest cover period of 8.13 day(s).
908 Devices Inc (MASS) estimates and forecasts
The year-over-year growth rate is expected to be -7.47%, down from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 11.9M in revenue for the current quarter. 4 analysts expect 908 Devices Inc to make 12.31M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 9.99M and 14.05M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 19.11%. Forecasts for the next quarter put sales growth at -12.35%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -32.72%.
MASS Dividends
908 Devices Inc’s next quarterly earnings report is expected to be released on 2025-Mar-03.
908 Devices Inc (NASDAQ:MASS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 8.09% of 908 Devices Inc shares, and 63.48% of them are in the hands of institutional investors. The stock currently has a share float of 69.07%. 908 Devices Inc stock is held by 113.0 institutions, with ARK INVESTMENT MANAGEMENT LLC being the largest institutional investor. By 2024-06-30, it held 12.0377% of the shares, which is about 3.94 million shares worth $20.28 million.
AMERIPRISE FINANCIAL INC, with 5.7552% or 1.88 million shares worth $9.7 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
ARK Genomic Revolution ETF and Columbia Small Cap Growth Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 2.96 shares worth $13.39 million, making up 8.37% of all outstanding shares. On the other hand, Columbia Small Cap Growth Fund held roughly 1.52 shares worth around $6.9 million, which represents about 4.31% of the total shares outstanding.
